PetMed Express (NASDAQ:PETS) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of PetMed Express (NASDAQ:PETS) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.

Other equities analysts have also issued research reports about the stock. Zacks Research raised shares of PetMed Express to a “hold” rating in a report on Thursday, April 30th. Weiss Ratings raised PetMed Express from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, PetMed Express has a consensus rating of “Reduce”.

PetMed Express Price Performance

Shares of PETS stock opened at $1.83 on Friday. The stock has a market cap of $39.11 million, a PE ratio of -1.33 and a beta of 0.76. The stock has a 50-day moving average of $1.91 and a 200-day moving average of $2.29. PetMed Express has a one year low of $1.57 and a one year high of $4.10.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.40). PetMed Express had a negative return on equity of 83.86% and a negative net margin of 17.34%.The firm had revenue of $41.02 million for the quarter, compared to the consensus estimate of $71.00 million. As a group, research analysts anticipate that PetMed Express will post 0.07 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PETS. Federated Hermes Inc. raised its holdings in shares of PetMed Express by 30.1% during the fourth quarter. Federated Hermes Inc. now owns 627,743 shares of the company’s stock worth $2,009,000 after acquiring an additional 145,357 shares during the period. BlackRock Inc. bought a new stake in PetMed Express in the 2nd quarter valued at $1,091,000. Dimensional Fund Advisors LP boosted its stake in PetMed Express by 5.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company’s stock worth $1,209,000 after purchasing an additional 24,624 shares during the period. Steel Partners Holdings L.P. bought a new position in PetMed Express during the 4th quarter worth about $620,000. Finally, Man Group plc raised its stake in shares of PetMed Express by 10.7% in the 4th quarter. Man Group plc now owns 167,152 shares of the company’s stock valued at $535,000 after purchasing an additional 16,113 shares during the period. Institutional investors and hedge funds own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.